Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
Ayala PharmaceuticalsREHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE)…
Ayala PharmaceuticalsREHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE)…
Subscribe to our newsletter to get our newest articles instantly!
Confirmed
0
Death
0
Sign in to your account